导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -16.98% | 953/1050 |
| 近一周 | -3.65% | 998/1104 |
| 近一月 | -1.79% | 327/1103 |
| 近一季 | -4.29% | 438/1092 |
| 近半年 | -18.97% | 983/1070 |
| 近一年 | -18.12% | 873/1018 |
| 近两年 | 14.19% | 819/926 |
| 近三年 | 9.10% | 603/834 |
| 成立以来 | 26.35% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.08% 825/1070 |
-18.72% 1056/1101 |
- - |
- - |
| 2025 | 22.75% 620/1065 |
5.10% 408/1014 |
5.53% 269/1038 |
12.83% 786/1050 |
-1.91% 551/1065 |
| 2024 | 15.57% 159/1011 |
3.85% 137/960 |
14.03% 1/983 |
2.71% 925/991 |
-4.98% 667/1011 |
| 2023 | -3.45% 171/952 |
6.32% 241/880 |
-3.06% 381/895 |
-3.11% 207/915 |
-3.32% 359/952 |
| 2022 | -4.64% 36/867 |
-2.74% 13/773 |
3.82% 587/806 |
-9.82% 234/845 |
4.71% 220/867 |
| 2021 | -5.94% 431/740 |
4.00% 63/580 |
-0.14% 545/659 |
-6.47% 401/704 |
-3.16% 547/740 |
| 2020 | 1.54% 403/554 |
-16.77% 409/419 |
4.35% 415/466 |
2.39% 397/517 |
14.17% 223/554 |
| 2019 | 9.99% 342/410 |
7.56% 1062/1146 |
-1.24% 460/1228 |
-3.67% 366/390 |
7.48% 262/410 |
| 2018 | -15.09% 27/349 |
- - |
-3.48% 152/990 |
0.65% 152/1000 |
-8.65% 189/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 前海开源港股通股息率50强 VS. 东吴新产业精选股票A(580008) |